Global WholeHealth Partners Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Edgar Gonzalez

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	2.1yrs
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

CEO

Edgar Gonzalez (60 yo)

2.1yrs

Permanencia

Mr. Edgar B. Gonzalez serves as Director at Global WholeHealth Partners Corporation since July 27, 2022. He serves as Chief Executive Officer & Chief Financial Officer at Glbl WholeHealth Ptnrs Corp. He se...

Global WholeHealth Partners Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

Global WholeHealth Partners Corporation Announces Appointment of F. Rene Alvarez, Jr. as Chief Executive Officer

Global Wholehealth Partners Corporation Announces Board and Executive Changes

Global WholeHealth Partners Corporation Appoints Miriam Lisbeth Páez De La Cerda to Serve as a Member of the Board of Directors

Recent updates

Global WholeHealth Partners Corporation announced delayed annual 10-K filing

Global WholeHealth Partners Corporation Announces Appointment of F. Rene Alvarez, Jr. as Chief Executive Officer

Global Wholehealth Partners Corporation Announces Board and Executive Changes

Global WholeHealth Partners Corporation announced delayed 10-Q filing

FDA Approves First COVID-19 Vaccine Which Can Be Distributed by Global WholeHealth Partners Corp

Global Wholehealth Partners, Corp. Confirms They Offer Antibody and Antigen Test Kits That Detect Fast Spreading Mutated COVID-19 Strains, DELTA (B.1.617.2), (UK (B.1.1.7), S. Africa (B. 1.351)

Global WholeHealth Partners Corporation Signs an Agreement with Dr. Vu Le to Be the Medical Director for the Clia Waived Mobile Laboratory

Global Wholehealth Partners Corp States the Antibody IgG/IgM Tests They Offer Are Capable of Detecting All the Current Identified Sars-Cov-2 Viruses

Global WholeHealth Partners Corporation announced delayed 10-Q filing

Global WholeHealth Partners Corp Announces That Global Is Now Offering the Astrazeneca Vaccines for $17.50 Per Vaccine

Global WholeHealth Partners Corp Receives from Nunzia Pharmaceutical the Full Right as Distributor of Nunzia to Sell the ADZ 1222 Covid 19 Vaccine by Thameen Healthcare Trading LLC

Global WholeHealth Partners Corp (GWHP-OTC) to Announce an Antibody “Confident” Test Which Can Detect the S1 RDT Antigen Used in COVID 19 Vaccines

Global WholeHealth Partners Corp. Offers an Antibody IgG/IgM Test Capable of Detecting the South Africa Strain (B.1.351) and the U.K. Strain (B.1.1.7), of COVID 19 SARS 2

First Ever Fda Authorized Over-The-Counter At-Home Rapid Test Kit for Coronavirus Backed by Biden Administration, as Global Wholehealth Partners Corp. Pioneers the Only Biodegradable Plant Based Plastic for Medical Devices

Global WholeHealth Partners Corporation's Antibody Test Can Detect the New CoViD 19 SARS 2 Strain

Global WholeHealth Partners Corporation Appoints Miriam Lisbeth Páez De La Cerda to Serve as a Member of the Board of Directors

Global WholeHealth Partners Corp. Now Offers the New FDA Cleared Fingerstick for Rapid COVID-19 Test Results in Minutes

Global WholeHealth Partners Corp. Submits an Emergency Use Authorization Application

CEO

Permanencia